Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection：a Prospective, Open-label, Randomized Controlled, Multicenter Clinical Trial

NCT06051513 is registered in ClinicalTrials.gov with Southeast University, China as lead sponsor.

NCT NCT06051513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06051513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection：a Prospective, Open-label, Randomized Controlled, Multicenter Clinical Trial
Lead sponsor
Southeast University, China
Phase
Not applicable
Overall status
Recruiting
Start date
November 27, 2023
Completion date
December 31, 2025
Enrollment
404 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

carbapenem-resistant enterobacteriaceae infection